hemoglobin level
The activated partial thromboplastin time (aPTT) test measures the intrinsic pathway of coagulation. It assesses the function of various clotting factors, including factors VIII, IX, XI, and XII, by evaluating the time it takes for blood to clot after the addition of an activator and phospholipids. Prolonged aPTT can indicate deficiencies or inhibitors in the intrinsic pathway.
INR is "International normalized ratio": it is a test for blood coagulation.
The term for a blood clot depends on whether the clot is stationary or has migrated into the blood stream. A stationary clot that is lodged in the heart or any other organ, is known as a "thrombus". If the blood clot goes elsewhere via the bloodstream, then it is called an embolism.
Blue test tubes are typically used for blood coagulation (BC) tests.
A lipid panel blood test measures fat substances in the blood. This test can determine the amount of good and bad cholesterol in the blood.
A lipid panel blood test measures fat substances in the blood. This test can determine the amount of good and bad cholesterol in the blood.
A Titer
A PTT-LA screen, or Partial Thromboplastin Time with Lupus Anticoagulant screen, is a blood test used to evaluate the coagulation pathway and detect the presence of lupus anticoagulants, which are antibodies that can interfere with the blood clotting process. It measures the time it takes for blood to clot and helps assess the risk of abnormal clotting or bleeding disorders. This test is particularly important in patients with unexplained thrombotic events or those with autoimmune conditions.
A laboratory test where venous blood is clotted in a test tube is called a serum clotting test. Once the blood sample clots, it is centrifuged to separate the liquid portion (serum) from the clot, which can then be used for various diagnostic tests.
with a blood test called a CBC "Complete Blood Count". It also measures a number of other things in the blood.
Thrombin time is a blood test that measures how long it takes for a clot to form in a plasma sample after the addition of thrombin. It is used to assess the functionality of the final steps of the coagulation process and can help diagnose clotting disorders such as fibrinogen deficiency or dysfibrinogenemia.
Capillary Coagulation Test